Persistent Asset Partners Ltd Acquires Shares of 93,563 Select Medical Holdings Corporation $SEM

Persistent Asset Partners Ltd bought a new stake in Select Medical Holdings Corporation (NYSE:SEM) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 93,563 shares of the health services provider’s stock, valued at approximately $1,420,000. Select Medical makes up 1.1% of Persistent Asset Partners Ltd’s investment portfolio, making the stock its 25th biggest holding.

A number of other institutional investors also recently modified their holdings of the business. Nuveen LLC bought a new stake in shares of Select Medical during the 1st quarter worth $12,133,000. Vanguard Group Inc. lifted its holdings in shares of Select Medical by 4.7% in the first quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider’s stock worth $222,378,000 after acquiring an additional 603,079 shares during the last quarter. Voya Investment Management LLC boosted its stake in shares of Select Medical by 48.7% in the 1st quarter. Voya Investment Management LLC now owns 1,507,349 shares of the health services provider’s stock valued at $25,173,000 after purchasing an additional 493,983 shares in the last quarter. Bridgeway Capital Management LLC increased its position in Select Medical by 43.1% during the 1st quarter. Bridgeway Capital Management LLC now owns 1,068,658 shares of the health services provider’s stock worth $17,847,000 after purchasing an additional 322,035 shares in the last quarter. Finally, Empowered Funds LLC lifted its stake in Select Medical by 96.0% in the 1st quarter. Empowered Funds LLC now owns 613,801 shares of the health services provider’s stock valued at $10,250,000 after purchasing an additional 300,631 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Price Performance

Shares of SEM opened at $13.08 on Friday. The business has a 50-day moving average of $13.23 and a 200-day moving average of $13.96. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The company has a market capitalization of $1.62 billion, a price-to-earnings ratio of 12.34, a price-to-earnings-growth ratio of 0.57 and a beta of 1.30. Select Medical Holdings Corporation has a 1 year low of $11.65 and a 1 year high of $39.74.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.33 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, equities research analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 25th. Investors of record on Wednesday, November 12th will be issued a $0.0625 dividend. The ex-dividend date is Wednesday, November 12th. This represents a $0.25 annualized dividend and a yield of 1.9%. Select Medical’s payout ratio is presently 29.07%.

Analysts Set New Price Targets

SEM has been the topic of a number of research reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, October 8th. Mizuho set a $17.00 target price on Select Medical in a report on Monday, November 3rd. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Royal Bank Of Canada upped their price objective on Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Finally, Bank of America cut their target price on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $17.80.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.